BridgeBio Pharma (2CL) Q4 2023 Earnings Report
DE:2CL Q4 2023 EPS Results
- Actual EPS
- -EUR 0.86
- Consensus EPS
- -EUR 0.78
- Beat/Miss
- Missed by -EUR 0.08
- One Year Ago EPS
- -EUR 0.82
DE:2CL Q4 2023 Revenue Results
- Actual Revenue
- EUR 1.56M
- Expected Revenue
- EUR 4.07M
- Beat/Miss
- Missed by -EUR 2.51M
- YoY Revenue Growth
- -6.68%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 02/22/2024
- Time
- Before Open
- Conference Call
- Thursday, February 22, 2024
DE:2CL Upcoming Earnings
BridgeBio Pharma's next earnings date is estimated for February 25, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2CL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 25, 2027 | 2026 (Q4) | -0.52- | -0.89 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | -0.48-0.38 | -0.85 | 55.79% (+0.47) | |
| Aug 10, 2026 | 2026 (Q2) | -0.52-0.70 | -0.85 | 17.89% (+0.15) | |
| May 07, 2026 | 2026 (Q1) | -0.61-0.75 | -0.79 | 4.55% (+0.04) | |
| Feb 24, 2026 | 2025 (Q4) | -0.64-0.89 | -1.25 | 28.57% (+0.36) | |
| Oct 29, 2025 | 2025 (Q3) | -0.80-0.85 | -0.77 | -10.47% (-0.08) | |
| Aug 05, 2025 | 2025 (Q2) | -0.71-0.85 | -0.35 | -143.59% (-0.50) | |
| Apr 29, 2025 | 2025 (Q1) | -0.82-0.79 | -0.18 | -340.00% (-0.61) | |
| Feb 20, 2025 | 2024 (Q4) | -1.00-1.25 | -0.86 | -45.83% (-0.39) | |
| Nov 12, 2024 | 2024 (Q3) | -0.90-0.77 | -0.97 | 20.37% (+0.20) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
